[go: up one dir, main page]

WO2004070345A2 - Age determination on death - Google Patents

Age determination on death Download PDF

Info

Publication number
WO2004070345A2
WO2004070345A2 PCT/GB2004/000125 GB2004000125W WO2004070345A2 WO 2004070345 A2 WO2004070345 A2 WO 2004070345A2 GB 2004000125 W GB2004000125 W GB 2004000125W WO 2004070345 A2 WO2004070345 A2 WO 2004070345A2
Authority
WO
WIPO (PCT)
Prior art keywords
age
bone
weight
air
fraction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/GB2004/000125
Other languages
French (fr)
Other versions
WO2004070345A3 (en
Inventor
Peter Zioupos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cranfield University
Original Assignee
Cranfield University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cranfield University filed Critical Cranfield University
Publication of WO2004070345A2 publication Critical patent/WO2004070345A2/en
Publication of WO2004070345A3 publication Critical patent/WO2004070345A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/84Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving inorganic compounds or pH
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483Physical analysis of biological material
    • G01N33/4833Physical analysis of biological material of solid biological material, e.g. tissue samples, cell cultures

Definitions

  • the invention relates to a method and means for determining the age of an individual at death.
  • a human has about 405 bones, over twice of that of the human adult who has 206 bones.
  • the reduction during ontogenetic development occurs as a result of multiple bones fusing to produce a single bone by a process known as epiphyseal union.
  • the fusion of bone epiphyses to metaphyses occurs at regular intervals and is therefore a useful indicator when quantifying the age of a skeletally immature individual at death.
  • Several bones can be examined, for example the iliac crest or the ileum bone of the os coax, the medial epiphyses of the clavicle, the tibia and the femur.
  • Bone is made up of two components, firstly an Organic Matrix that comprises type I collagen fibrils (90% of the whole matrix) and non-collagenous components such as proteins, proteoglycans, phospholipids, glycoproteins and phosphoproteins (the remaining 10% of the matrix).
  • the second component is known as the mineral substance, calcium phosphate hydroxyapatite.
  • the collagen fibrils are the result of the assemblage of filamentous molecules. Bundles of microfibrils then form larger fibrils that, in turn, form larger fibres. Thus there is an orderly packing of collagen within bone structure.
  • the non- collagenous component seems to play an important role in the degree of calcification of the bone.
  • Figure 1 there is shown a cross section of bone under an electron microscope.
  • the structure essentially, comprises area of primary bone (I) and areas of secondary osteons (O).
  • the primary bone (I) represents older tissue
  • long bones i.e. long tubular segments of bone such as those found in the limbs, ribs and clavicles, and in particular bone from the femur.
  • bones include short bones, i.e. those short irregular prismatic structures such as those found in the vertebrae, sternum, carpus and tarsus or flat bones, i.e. the bilaminar plates found in the skull, scapula and pelvis.
  • osteons are orientated parallel to the axis of the bone, with an inclination of about 5 to 15°. They comprise harvesian canals which generally contain blood vessels, nerve fibres and a variety of other cell types.
  • Primary osteons are formed early in life and their number diminishes with increasing age. Secondary osteons form throughout life, increasing more with aging, and in bone physiology play a crucial role because they repair in-vivo cracks and allow for internal remodelling of the bone structure. Primary osteons tend to be on average well mineralised. Secondary osteons start with low mineral content and gradually mineralise more and more but not to the level of primary osteons because they are produced much later in life.
  • Woven bone which can be formed rapidly in a disorganised manner, like in the callous formation when bone breaks. Its collagen fibres and mineral crystallites are randomly orientated in space. Woven bone has an intermediate level of mineralisation, but with more and more time in the body it mineralises considerably.
  • Lamellar bone which is formed in a circumferential manner around the cortex of bones earlier in life. It is densely mineralised and it becomes more so with time in the body.
  • a method for determining the "age at death" of an individual which method comprises obtaining a sample of bone from said individual and determining a plurality of properties thereof, then using these properties to determine said "age at death”.
  • said properties comprise at least two of the following properties: relative content of calcium to phosphorous; hardness; density; porosity; weight fraction measurements or degradation parameters (from Differential Scanning Calorimetry).
  • the invention involves the measurement of at least one or more of the following parameters: Apparent density; Real density;
  • Water Fraction (wet weight in air - dry mineralised weight in air) / wet weight in air.
  • Organic fraction dry demineralised weight / wet weight in air.
  • Age -192 + 150 (Ap.D./R.D.)+2.92(10gf in Osteon)-0.281 (Delta H Demin.)
  • Age -264-2481 (Water Fraction) + 6.8(1 Ogf in Osteon)-6.76(1 Ogf in Matrix)
  • the dry mineralised weight (in grams) of the samples were also measured in air, at ambient room temperature and humidity, after the samples have been left to dry for 5 days and 7 days, at +39°C in the hotbox oven. Great care was undertaken to eliminate the factor of humidity from the measuring process.
  • Hardness of a solid material is defined as the resistance it exhibits towards penetration by another solid.
  • Microhardness testing is accomplished by indenting the material under investigation with a specially designed microscope mounted with a very small indenter.
  • the type of the indenter used was a VickersTM. This is a pyramidal diamond indenter with an apical angle of 136°.
  • INDENTEC HWDM-7 Vickers microhardness number (HV) is given by the following equation:
  • DSC Differential Scanning Calorimetry
  • Temperature/Heat Flow spectra were obtained by a PERKIN ELMER PYRIS 1 , DISC unit. An identical methodology was used to examine the previously demineralised samples, although the aluminium crucibles used were from the METLER HANDLING SET ME-119091 , and the DSC unit used was METLER M3 DISC UNIT. In both the mineralised and demineralised samples, the values of Peak temperature of collagen degradation and the total energy needed were measure. The samples were heated from 30°C up to 300°C at a heating rate of 5.00°C per min. The extrapolation of the data was performed automatically from the software used by both DSC units. An explanation of the extrapolation process is shown below in Figure 4.
  • the accelerating voltage used was 10.00keV, with a takeoff angle of 40°, for the period of 200 seconds, in each location measured.
  • the ratio values were calculated automatically from the spectra produced, by the PGT software used by the detector. Again, it is to be noted that, as per the formula above, it is sufficient to measure the Calcium to Phosphorous ratio for Matrix tissue.
  • the actual age of the individual at the time of death against the predicted values of age at the time of death can be determined by using Formula 4.
  • Formula 4 suggests that the combined knowledge and usage of parameters, such as hardness of bone measured in the osteons and in the matrix and the Delta H energy of the demineralised samples of bones can make possible accurate predictions of age in mature adult bone.
  • Age - 23.6 + 2.36(1 Ogf in Osteon) - 27.8(Ca/P% in Matrix) + UA (Organic Fraction.)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Inorganic Chemistry (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

The invention relates to a method and means for determining the 'age at death' of an individual using only a sample of bone from said individual. The method involves determining a plurality of properties of the said bone and then using these properties to determine 'age at death'.

Description

AGE DETERMINATION ON DEATH
The invention relates to a method and means for determining the age of an individual at death.
One of the most essential aspects in any identification process where there is extensive damage to a corpse or where human remains are rendered unrecognisable by advanced decomposition is the "age at death". This is one of four important attributes that a forensic anthropologist or pathologist has to determine. The other three are sex, stature and ethnic background. An accurate estimation of "age at death" is more important in forensic anthropology than in archaeological cases because the required accuracy is higher and there may be possible legal consequences of correct versus incorrect determinations.
For the avoidance of doubt the cause of death may be due to natural circumstances, homicide, suicide, mass disaster or even war crimes including massacres caused by religious or ethnic cleansing.
Identification of the age of an individual at death becomes increasingly difficult after the individual has reached skeletal maturity. This is because aging is orchestrated by the complicated interplay of genetic, environmental and cultural factors, meaning that not everyone ages the same.
However, until skeletal maturity is reached, at the age of 30 to 35, if presented with a complete corpse, one can use a number of methods to determine the "age at death". For example, a relatively precise biological assessment, i.e. plus or minus 3 years, can be obtained by examining the chronology of dental eruption in respect of deciduous or permanent teeth. Additionally, degenerative changes occurring in teeth can also give an indication of age. These degenerative changes include tooth wearing and tooth loss. Additionally or alternatively, the fusion of the epiphyses is a further anatomical means for determining the "age at death".
At the time of birth a human has about 405 bones, over twice of that of the human adult who has 206 bones. The reduction during ontogenetic development occurs as a result of multiple bones fusing to produce a single bone by a process known as epiphyseal union. During ontogenetic development the fusion of bone epiphyses to metaphyses occurs at regular intervals and is therefore a useful indicator when quantifying the age of a skeletally immature individual at death. Several bones can be examined, for example the iliac crest or the ileum bone of the os coax, the medial epiphyses of the clavicle, the tibia and the femur. Advantageously, there are some gender variations with female epiphyses fusion occurring earlier than males. Moreover, in the aging assessment the fusion of a particular bone is usually classified into stages: nonunion, one-quarter united, one-half united, three-fourths united, and fully fused or full union. These are all useful indicators in determining the age of death of an individual with an immature skeleton. A further approach for determining "age at death" involves histomorphological features of the bone matrix based on the size of the mid-femur, the level of porosity and the relative number of primary and secondary osteonal systems. But, again, these methods are increasingly inaccurate after maturity.
The only reported analytical technique available for determining the "age at death" of a mature individual is based on the determination and exploitation of changes in the L and D forms of aspartic acid. The L converts to the D form in the non-collagenous organic matrix of bone and other tissues during the life of an individual (Nature: 1976, 262: 279 - 281). This technique has been shown to provide estimates with an accuracy of + 10 years. Whilst it is a step in the right direction the margin of error can render it ineffective. Moreover, it requires elusion methods, HPLC methods and is affected by many preparatory factors like pH, size of bone crushed particles, washing of bone tissue, the amount of bone tissue, the concentration and amount of the used acidic solutions, and the manner of agitation.
It can therefore be seen that there is a need to provide a new method and means for determining the age of an individual at death and in particular the age of a mature individual, or adult, at death. Further, this method needs to be sufficiently flexible that it can be used in instances where the corpse has been subjected to substantial damage and there may be only a small fragment of bone tissue to work with. Bone is living, growing, specialised tissue. It can be regarded as highly heterogeneous in the sense that its structure and composition varies according to skeletal size, physiological function, age and sex of the individual. Nevertheless, the basic components of bone tissue remain consistent with age the difference being in the relative properties of the tissue.
Bone is made up of two components, firstly an Organic Matrix that comprises type I collagen fibrils (90% of the whole matrix) and non-collagenous components such as proteins, proteoglycans, phospholipids, glycoproteins and phosphoproteins (the remaining 10% of the matrix). The second component is known as the mineral substance, calcium phosphate hydroxyapatite. The collagen fibrils are the result of the assemblage of filamentous molecules. Bundles of microfibrils then form larger fibrils that, in turn, form larger fibres. Thus there is an orderly packing of collagen within bone structure. The non- collagenous component seems to play an important role in the degree of calcification of the bone.
In Figure 1 there is shown a cross section of bone under an electron microscope. The structure, essentially, comprises area of primary bone (I) and areas of secondary osteons (O). The primary bone (I) represents older tissue
and has a greater degree of calcification, so that it appears lighter. In contrast, the newer bone, which is less calcified, appears darker. In the experiments described herein we have used long bones, i.e. long tubular segments of bone such as those found in the limbs, ribs and clavicles, and in particular bone from the femur.
Other sorts of bones include short bones, i.e. those short irregular prismatic structures such as those found in the vertebrae, sternum, carpus and tarsus or flat bones, i.e. the bilaminar plates found in the skull, scapula and pelvis.
The method of the invention can be applied to any of these bone types in any species.
In the long bones osteons are orientated parallel to the axis of the bone, with an inclination of about 5 to 15°. They comprise harvesian canals which generally contain blood vessels, nerve fibres and a variety of other cell types.
Primary osteons are formed early in life and their number diminishes with increasing age. Secondary osteons form throughout life, increasing more with aging, and in bone physiology play a crucial role because they repair in-vivo cracks and allow for internal remodelling of the bone structure. Primary osteons tend to be on average well mineralised. Secondary osteons start with low mineral content and gradually mineralise more and more but not to the level of primary osteons because they are produced much later in life.
Other types of bone include Woven bone which can be formed rapidly in a disorganised manner, like in the callous formation when bone breaks. Its collagen fibres and mineral crystallites are randomly orientated in space. Woven bone has an intermediate level of mineralisation, but with more and more time in the body it mineralises considerably.
Another type of bone is Lamellar bone which is formed in a circumferential manner around the cortex of bones earlier in life. It is densely mineralised and it becomes more so with time in the body.
With increasing age the bone matrix experiences changes which are constitutional, compositional, micromechanical and/or physiochemical in nature. These changes affect the material properties of bone and we have investigated them with a view to determining whether they have any predictive power with a view to using them to determine the age of an individual at death. Our experiments have led us to conclude that these changes can be quantified and, when correctly processed, used to predict, with remarkable accuracy, i.e. + one year, the age of an individual from which the bone originated.
In the methodology to be described herein we have used long bones from males and females who are beyond the level of skeletal maturity. However, it can equally be successfully applied to individuals younger than this and for bones of the body other than the femur. STATEMENTS OF INVENTION
According to a first aspect of the invention there is provided a method for determining the "age at death" of an individual which method comprises obtaining a sample of bone from said individual and determining a plurality of properties thereof, then using these properties to determine said "age at death".
In a preferred embodiment of the invention said properties comprise at least two of the following properties: relative content of calcium to phosphorous; hardness; density; porosity; weight fraction measurements or degradation parameters (from Differential Scanning Calorimetry).
In yet a further preferred embodiment the invention involves the measurement of at least one or more of the following parameters: Apparent density; Real density;
Porosity; Mineral Fraction; Water Fraction or Organic Fraction wherein:
Apparent density = Ap.D. = wet weight in air / volume.
Real density = R.D. = wet weight in air / (wet weight in air - wet weight in water). Porosity = 1- (Apparent density / Real density).
Mineral Fraction = (dry mineralised weight - dry demineralised weight) / wet weight in air.
Water Fraction = (wet weight in air - dry mineralised weight in air) / wet weight in air. Organic fraction = dry demineralised weight / wet weight in air.
According to a further aspect of the invention there is therefore provided a method for determining the "age at death" of an individual comprising taking a sample of bone from a corpse of said individual and subjecting said bone to laboratory analysis to determine any one or more of the following parameters:
a) the relative content of calcium to phosphorous; b) hardness; c) Organic Fraction, i.e. dry demineralised weight / wet weight in air; d) Water fraction, i.e. (wet weight in air - dry mineralised weight in air) / wet weight in air; e) Mineral Fraction, i.e. (dry mineralised weight - dry demineralised weight) / wet weight in air; or f) collagen degradation or a DSC value
and then feeding this information into any one or more of the following equations.
1 ) Age = 55.6 + 161 (Organic Fraction) - 0.253 (Delta H Demin.)
2) Age = -81.9 + 2.99 ( Ogf in Osteon) - 0.164 (Delta H Demin.)
3) Age = -86.0 + 2.63 (10gfin Matrix) - 0.134 (Delta H Demin.) 4) Age = - 88.4 + 1.52 (10gf in Osteon) + 1.36(10gf in Matrix) - 0.146(Delta H Demin.)
5) Age = - 23.6 + 2.36(1 Ogf in Osteon) - 27.8(Ca/P% in Matrix) +
14.1 (Organic Fraction. )
6) Age = 564 - 733(Organic Fraction) - 723(Mineral Fraction) -0.066(1 Ogf in Osteon) + 2.90(1 Ogf in Matrix)
7) Age = 105 - 9.3 (1 Ogf in Osteon) + 8.26 (lOgf in Matrix) -0.414 (Delta H Demin.)
8) Age = -192 + 150 (Ap.D./R.D.) + 2.92 (lOgf in Osteon) -0.281 (Delta H Demin.)
9) Age = -264 - 2481 (Water Fraction) + 6.Q(10gf in Osteon) - 6.76(10gf in Matrix)
In a preferred embodiment of the invention a) the relative content of calcium to phosphorous and/or b) hardness is determined for osteons and/or interstitial (Matrix) tissue. Most preferably equations 5 + 6 are used to estimate the "age at death" of a sample believed, or suspected, to be of male origin and equations 7, 8 or 9 are used to estimate the "age at death" of a sample believed, or suspected, to be of female origin.
In yet a further preferred embodiment of the invention said methodology employs the use of a standard wherein bone from an individual whose age is known is analysed in parallel with a sample of bone whose "age at death" is to be determined.
More preferably a plurality of standards are used, and most ideally bone from at least one relatively young individual is used and bone from at least one relatively old individual is used. Advantageously, bone from an individual of 30 years of age is used as one standard and bone from an individual of 70 years of age is used as a second standard.
The use of standards is particularly preferred where samples from a number of different species are analysed and most preferably the standards used are selected (in terms of their ages and species) on the basis of the species whose bone is thought to be under investigation.
In yet a further aspect of the invention there is provided means for performing the above methodology wherein said means comprises a resin block in which there is embedded a sample of bone whose age is to be determined and at least one other standard as herein described.
By using the aforementioned parameters, and in particular at least two thereof, it is possible to predict the "age at death" with some accuracy as indicated below where R2 + p are the levels of significance between predicted and actual age values based on a validation test sample of 12 individuals: 7 male, 5 female.
1 ) Age = 55.6 + 161 (Organic Fraction) - 0.253 (Delta H Demin.)
(p=0.043) (p=0.025) (p=0.070) R2 = 55.6% Readjusted) = 45.7% p = 0.026
2) Age = -81.9 + 2.99 (1 Ogf in Osteon) - 0.164 (Delta H Demin.)
(p=0.001) (p=0.000) (p=0.004)
R2=94.8% R2(adjusted)=93.7% p=0.000
3) Age = -86.0 + 2.63 (10gfin Matrix) - 0.134 (Delta H Demin.) (p=0.001) (p=0.000) (p=0.0012)
R2=94.9% R2(adjusted)=93.8% p=0.000
4) Age = -88.4+1.52 (10gf in Osteon)+ 1.36(1 Ogf in Matrix)-0.146(Delta H
Demin)
(p=0.000) (p=0.072) (p=0.068) (p=0.004)
R2=96.7% R2(adjusted)=95.4% p=0.000 5) Age = -23.6+2.36(1 Ogf in Osteon)-27.8(Ca/P% in Matrix)+ 4Λ (0rganic Fraction.)
(p=0.802) (p=0.065) (p=0.465) (p=0.813)
R2= 90.5% R2(adjusted)=80.9% p=0.049
6) Age = 564-733 (Organic Fraction)-723(Mineral Fraction)-0.066(1 Ogf in Osteon)+2.90(10gfin Matrix)
(p=0.401 ) (p=0.353) (p=0.346) (p=0.949) (p=0.062)
R2=98.6% R2(adjusted)=95.8% p=0.028
7) Age = 105 - 9.3(10gf in Osteon)+8.26(1 Ogf in Matήx)-0A 4(Delta H Demin.)
(p=0.066) (p=0.140) (p=0.185) (p=0.329)
R2=99.5 R2(adjusted)=98.2 p=0.086
8) Age = -192 + 150 (Ap.D./R.D.)+2.92(10gf in Osteon)-0.281 (Delta H Demin.)
(p=0.887) (p=0.826) (p=0.900) (p=878)
R2=94.8 R2(Adjusted)=79.3% p=0.287
9) Age = -264-2481 (Water Fraction) + 6.8(1 Ogf in Osteon)-6.76(1 Ogf in Matrix)
(p=0.016) (p=0.070) (0.027) (0.038)
R2=100.0 R2(adjusted)=99.9 p=0.019 MATERIALS AND METHODS
All the experiments achieved during this project were performed from bone received from the North London Tissue Bank. The bone received was from 7 males and 7 females of various ages, who had died from causes that did not affect the experimental requirements of the bones, and had not been hospitalised for any length of time. The bones were transported in plastic bags packed with ice; subsequently they were thoroughly washed with running water and finally were stored in plastic bags at -20°C. During sample preparation and according to the requirements of several of the experiments performed, a number of samples were either stored in airtight containers at -20°C with saline solution, or in class container at +39°C, in a GALLENKAMP Hot Box Oven Size 1.
The bone tissue used was freely donated.
DENSITY AND POROSITY AND WEIGHT FRACTION MEASUREMENTS Wet Weight in Water (WWW) Initially the diameter and height of all the samples was measured (in mm) by the means of a Digital Caliper MITUTOYO ABSOLUTE DIGIMATIC, and therefore their volume (in mm3) was calculated by multiplying the two together. During the measuring processes, several measurement of the height and diameter were taken from each sample in order to establish the lower and higher values which was finally averaged. The digital calliper measured up to two decimal places and the error values for this instrument was determined to be approximately 0.01mm. Nevertheless, the measurements were taken up to three decimal places, due to the calculation processes.
Following the measurements the samples were centrifuged immersed in deionised water for 3 min at lOOOrpm in a MISTRAL 1000 unit. Centrifugation was performed in order to ascertain the water uniformity in the pores of the samples. Subsequently the wet weight in water (in grams) of the samples was measured under water by using a metal tray provided for measurement of density of solid materials by the Archimedes principle. All measurements were performed by the means of a high precision METLER TOLEDO College B154 balance at room temperature. The precision balance measurements were displayed with four decimal places, and with an error of approximately 0.0001 to 0.0002 g.
Wet Weight in Air (WWA)
After that the samples were centrifuged again for 3 min at lOOOrpm, but this time wrapped in a wet cloth in order to remove excess amounts of water from the major pores found in the bone matrix of the samples. Thereafter the samples were again wet weighted, but this time in air, and not immersed in water, at room temperature, therefore producing the wet weight in air (in grams). Dry Mineralised Weight (DMW)
The dry mineralised weight (in grams) of the samples were also measured in air, at ambient room temperature and humidity, after the samples have been left to dry for 5 days and 7 days, at +39°C in the hotbox oven. Great care was undertaken to eliminate the factor of humidity from the measuring process.
Dry Demineralised Weight (DDW)
Subsequently some samples were selected and demineralised with the use of Ethylenediaminetetraacetic acid 0.5M, pH=7.4 (EDTA), by continuously stirring the samples for a period of 13 days and by changing the solution 7 times. After the demineralisation process was finished, the samples were thoroughly washed to remove EDTA, and were dried out, for a period of 5 days. Following drying, the samples were weighed (in grams), at ambient temperature and humidity, so determining the dry demineralised weight, which basically is the weight of the organic material of the bone matrix.
Calculations
The following calculation processes were used in order to determine, Apparent Density (ApD), Real Density (RD), Porosity (P), Mineral Fraction (MF), Water Fraction (WF), and finally Organic Fraction (OF). Due to the fact that weight measurements were measured up to four decimal places, in addition to the volume measurements, which were obtained up to three decimal places, in all the calculation precision used was up to four decimal places. (2) Apparent Density = Ap.D. = WWA / Volume
(3) Real Density = R.D. = WWA / (WWA - WWW)
(4) Porosity = P = 1 - (ApD / RD)
(5) Mineral Fraction = MF = (DMW - DDW) / WWA (6) Water fraction = WF = (WWA - DMW in air) / WWA
(7) Organic Fraction = OF = DDW / WWA
Microhardness Measurements
Hardness of a solid material is defined as the resistance it exhibits towards penetration by another solid. Microhardness testing is accomplished by indenting the material under investigation with a specially designed microscope mounted with a very small indenter. In this case, the type of the indenter used was a Vickers™. This is a pyramidal diamond indenter with an apical angle of 136°. Although the microhardness values obtained were automatically calculated by the testing device, INDENTEC HWDM-7, Vickers microhardness number (HV) is given by the following equation:
HV = 2P sin (θ/2) / d2 Where: P = applied load in Kg d = mean length of di and d2 in mm, the two diagonal of the indentation
(see Figure 3.4) θ = 136°
For the purposes of this experiment, the samples under investigation were embedded in resin METPREP Polyester Castins Resin KLEER-SET TYPE SSS, in a BUEHLER VACUUM IMPREGNATION EQUIPMENT I, and left to dry. Following drying the samples were metallurgically polished to mirror finish, in a METESERV rotary pregrinder, by the use of 800 and 1200 Grinding paper and finally with a polish cloth, MASTERTEX, with adhesive backing under
MICROPOLISH ALUM 3B 6OZ. Great care was undertaken to assure a good quality polished area. Indentation values were obtained for secondary osteons, and interstitial lamellae from five locations in each sample, in the following fashion, north, south, east, west and from the centre. The indentation loads used in each location were 10gf, 50gf and 100gf. The experimentation processes are illustrated in Figure 2. However, it is to be noted that, as per the formulae above, it is sufficient to measure hardness using only one load in either Osteon or Matrix tissue.
But in these experiments, in total, 30 hardness values were obtained from each sample, and in general, 360 indentations were performed. Different weights were used for selection purposes due to the fact that different weights produce different indentation diagonals, and therefore the easiness of measuring under the microscope varies according to weight. The error observed during these processes was found to be approximately + 1-2 Vickers hardness units. During experimentation, great care was undertaken to avoid confounding factors such as, levelling the sample thus allowing the indenter to penetrate in right angles, keeping the loading mechanism free of any vibrations, and discarding asymmetric or problematic readings. Differential Scanning Calorimetry Measurements
Differential Scanning Calorimetry (DSC) subjects a material and a reference to the same heat treatment, with the purpose of measuring the amount of energy necessary for the material to maintain the same temperature as that of the reference. In this project, DSC was used to determine the thermodynamic parameters of the denaturation of bone collagen, in the mineralised and demineralised state.
The samples under investigation were initially thinned down manually by the use of grinding paper, under continuous irrigation, to approximately 1 to 2mm in height, and left to dry for 5 days. Following drying, the mineralised samples under investigation, were, firstly weighted in a METLER AJ50 precision balance, secondly embedded in PYRIS 1 aluminium crucibles, and finally their
Temperature/Heat Flow spectra were obtained by a PERKIN ELMER PYRIS 1 , DISC unit. An identical methodology was used to examine the previously demineralised samples, although the aluminium crucibles used were from the METLER HANDLING SET ME-119091 , and the DSC unit used was METLER M3 DISC UNIT. In both the mineralised and demineralised samples, the values of Peak temperature of collagen degradation and the total energy needed were measure. The samples were heated from 30°C up to 300°C at a heating rate of 5.00°C per min. The extrapolation of the data was performed automatically from the software used by both DSC units. An explanation of the extrapolation process is shown below in Figure 4.
It is to be noted that, as per the formulae above, it is sufficient to measure the DSC value of only the demineralised samples.
ENERGY DISPERSIVE ANALYSIS MEASUREMENTS
Mineral characterisation of the samples, their Calcium to Phosphorous ratio, was accomplished by Energy Dispersive Analysis through X-rays (EDAX). EDAX is specialised detector mounted upon a Scanning Electron Microscope (SEM) unit.
The previously embedded in resin samples (used in Vickers Microhardness) were carbon coated, in a FISONS INSTRUMENTS CARBON COATER, and were analysed with a PRINCENTON GAMMA TECH PGT IMIX MICROANALYSER EDAX detector. The detector was mounted on a JEOL JSM-840A SEM unit. In general, four calcium to phosphorus, ratio values were obtained from each sample. Two values were obtained from secondary osteons, and two from interstitial matrix lamellae. The variables obtained were the percentage values of the normal weights of calcium and phosphorus. The ratio values were calculated by dividing the calcium values with those of the phosphorus. The accelerating voltage used was 10.00keV, with a takeoff angle of 40°, for the period of 200 seconds, in each location measured. The ratio values were calculated automatically from the spectra produced, by the PGT software used by the detector. Again, it is to be noted that, as per the formula above, it is sufficient to measure the Calcium to Phosphorous ratio for Matrix tissue.
CONCLUSIONS
Age Determination for Mixed Samples
The above analysis was carried out in respect of each sample of bone tissue and as a result a vast amount of data was collected. We then sifted through this data and discovered that when age was correlated with organic fraction and DSC values, i.e. Delta H of the demineralised samples, it produced a regression formula with an R2 value of 55.6% and p = 0.026.
Formula 1
Age = 55.6 + 161 (Organic Fraction) - 0.253(Delta H Demin.) (p=0.043) (p=0.025) (p=0.070) R2 = 55.6% Readjusted) = 45.7% p = 0.026
Following the same approach when age was examined in correlation with the Vickers Microhardness results for the weight of 10gf in the osteons and the Delta H demineralised samples a highly significant Formula 2 was produced in relation to age with an R2 value of 94.8% and p = 0.000.
Formula 2
Age = -81.9 + 2.99 (10gfin osteons) - 0.164 (Delta H demin.) (p = 0.001) (p=0.000) (p=0.004) R2 = 94.8% Readjusted) = 93.7% p=0.000
In Formula 3 age was correlated with the Vickers microhardness results for the 10gf weight in the matrix, and the Delta H of the demineralised samples producing a slightly higher significant regression formula than Formula 2 with R2 values of 94.9%, p=0.000 and residuals ranging from approximately -4 to +4 years. Again, all of the coefficients were found to be highly significant.
Formula 3
Age = -86.0 + 2.63 (10gfin Matrix) - 0.134 (Delta H demin.) (p=0.001) (p=0.000) (p=0.0012)
R2 = 94.9% Readjusted) = 93.8% p=0.000
The most successful relationship of all was when age was correlated with, the Vickers microhardness results for weights of 10gf in the osteons and in the matrix, in addition to Delta H demineralisation. The statistical results of this regression Formula 4 showed a surprisingly R2 value of 96.7% and p=0.000/ Nevertheless, the level of significance of the coefficients was not highly significant in the cases of the Vickers microhardness results rather than formulas, but the table of residuals showed a fluctuation between approximately -3 to +3 years.
Formula 4
Age = -88.4 + 1.52 (10gf in Osteon) +1.36(1 Ogf in Matrix) -0.146(Delta H Demin) (p=0.000) (p=0.072) (p=0.068) (p=0.004)
R2=96.7% R2(adjusted)=95.4% p=0.000
The actual age of the individual at the time of death against the predicted values of age at the time of death can be determined by using Formula 4. Formula 4 suggests that the combined knowledge and usage of parameters, such as hardness of bone measured in the osteons and in the matrix and the Delta H energy of the demineralised samples of bones can make possible accurate predictions of age in mature adult bone.
Age Determination for the Male Samples
A similar approach as that followed for the mixed sample group was followed for the male and female samples as well. With the unknown as age, several combinations of several parameters were tested in order to establish the most successful formula for age determination at death, at least knowing the sex of individual.
Initially for males, a combination of Vickers Micro hardness results with weight 10gf in the osteons, with calcium and phosphorous ratio in the matrix, and the organic fraction, produced Formula 5 with R2 values of 90.5% and p=0.049.
Nevertheless, the coefficient level of significant was found not to be significant, and residuals ranged from approximately -5 to +4 years. Formula 5
Age = - 23.6 + 2.36(1 Ogf in Osteon) - 27.8(Ca/P% in Matrix) + UA (Organic Fraction.)
(p=0.802) (p=0.065) (p=0.465) (p=8.13) R2=90.5% R2(adjusted)=80.9% p=0.049
In a second attempt to determine age at death for males, a combination of Organic fraction, mineral fraction, and Vickers Micro hardness results with 10gf weight in the osteons and in the matrix, produced the most successful formual 6 with R2 values of 98.6 and p=0.028. On the other hand, the coefficients level of significant was found not to be significant, as on Formula 5. Interestingly residuals ranged approximately between -1 to +2 years. The data for this formula is shown in Figure 5.
Formula 6
Age = 564 - 733(Organic Fraction) - 723(Mineral Fraction) - 0.066(1 Ogf in Osteon) + 2.90 (10gfin Matrix)
(p=0.401) (p=0.353) (p=0.346) (p=0.949) (p=0.062)
R2=98.6% R2(adjusted)=95.8% p=0.028
Age Determination for the Female Samples
In female samples, the Vickers micro hardness measurements with 10gf weights in the osteons and in the Matrix, were combined with Delta H measurements in the demineralised samples. This Formula 7 was proven to be more successful than the previous one with an R2=of 99.5, but still the significance level of the formula but as well of the coefficient was still less successful. The residuals ranged approximately between -0.305 - 0.26 years.
Formula 7
Age = 105 - 9.3 (10gf in Osteon) + 8.26 (10gf in Matrix) - 0.414 (Delta H Demin.)
(p=0.066) (p=0.140) (p=0.185) (p=0.329)
R2=99.5 R2(adjusted)=98.2 p=0.086 Also in the female samples, a combination of Apparent density over Real density, with the results from Delta H in the demineralised samples, and Vickers micro hardness measurements with 10gf weights in the osteons, produced a formula 8 with R2 values of 94.8% but the significance level of the formula as well for the coefficients was less successful. The residuals ranged from -1.2 to 0.02 years.
Formula 8
Age = -192 + 150 (Ap.D./R.D.) + 2.92 (10gfin Osteon) -0.281 (Delta H Demin.) (p=0.887) (p=0.826) (p=0.900) (p=878) R2=94.8 R2(Adjusted)=79.3% p=0.287
Astonishingly enough Formula 9 proved to be the most successful of all in female samples with an R2 value of 100.0% and p=0.019. In this formula, the water fraction was combined with the Vickers micro hardness measurements with 10gf weights in the osteons and in the Matrix. In addition all the significant levels of the coefficient were under acceptable limits (p<0.05) except that of the Water Fraction (p=0.070), and the residuals showed not significant deviation from the actual ages of the females examined. The data for this formula is shown in Figure 5.
Formula 9
Age = -264 - 2481( Water Fraction) + 6.8(10gfin Osteon) - 6.76(10gfin Matrix) (p=0.016) (p=0.070) (0.027) (0.038) R2=100.0 R2(adjusted)=99.9 p=0.019

Claims

1. A method for determining the "age at death" of an individual which method comprises obtaining a sample of bone from said individual and determining a plurality of properties thereof, then using these properties to determine said "age at death".
2. A method according to Claim 1 wherein said properties comprise at least two of the following properties: relative content of calcium to phosphorous; hardness; density; porosity; at least one Weight Fraction measurement; or collagen degradation parameters.
3. A method according to Claim 1 or Claim 2 comprising a determination of any one or more of the following properties: Apparent density; Real density; Porosity; Mineral Fraction; Water Fraction or Organic Fraction.
4. A method according to Claim 3 wherein said Apparent density = wet weight in air / volume.
5. A method according to Claim 3 wherein Real density = wet weight in air / (wet weight in air - wet weight in water).
6. A method according to Claim 3 wherein Porosity = 1 -(Apparent density / Real density).
7. A method according to Claim 3 wherein Mineral Fraction = (dry mineralised weight - dry demineralised weight) / wet weight in air.
8. A method according to Claim 3 wherein Water Fraction = (wet weight in air - dry mineralised weight in air) / wet weight in air.
9. A method according to Claim 3 wherein Organic Fraction = dry demineralised weight / wet weight in air.
10. A method for determining the "age at death" of an individual comprising taking a sample of bone from a corpse of said individual and subjecting said bone to laboratory analysis to determine any one or more of the following parameters:
(a) the relative content of calcium to phosphorous;
(b) hardness;
(c) Organic Fraction, i.e. dry demineralised weight / wet weight in air;
(d) Water Fraction, i.e. (wet weight in air - dry mineralised weight in air) / wet weight in air;
(e) Mineral Fraction, i.e. (dry mineralised weight - dry demineralised weight) / wet weight in air; or
(f) collagen degradation or a DSC value; and then feeding this information into one or more of the following equations: (1 ) Age = 55.6 + 161 (Organic Fraction) - 0.253 (Delta H Demin.)
(2) Age = -81.9 + 2.99 (lOgfin Osteon) - 0.164 (Delta H Demin.)
(3) Age = -86.0 + 2.63 (10gfin Matrix) - 0.134 (Delta H Demin.)
(4) Age = -88.4 + 1.52 (10gf in Osteon) + 1.36(1 Ogf in Matrix) - 0.146(Delta H Demin.) (5) Age = -23.6 + 2.36(1 Ogf in Osteon) - 27.8(Ca/P% in Matrix) +
14.1 (Organic Fraction. ) (6) Age = 564 - 733(Organ/c Fraction) - 723{Mineral Fraction) - 0.066(70gf in Osteon) + 2.90(1 Ogf in Matrix) (7) Age = 105 - 9.3 (10gf in Osteon) + 8.26 (10gf in Matrix) - 0.414 (Delta H Demin.)
(8) Age = - 192 + 150 (Ap.D./R.D.) + 2.92(1 Ogf in Osteon) - 0.281 (Delta H Demin.) (9) Age = -264 - 2481 (Water Fraction) + 6.8(1 Ogf in Osteon) - 6.76(1 Ogf in
Matrix).
11. A method according to Claim 10 wherein:
(a) the relative content of calcium to phosphorous and/or
(b) hardness is determined for Osteons and/or interstitial (Matrix) tissue.
12. A method according to Claim 10 wherein equations (5) and (6) are used to estimate the "age at death" of a sample believed, or suspected, to be of male origin.
13. A method according to Claim 10 wherein equations (7), (8) or (9) are used to estimate the "age at death" of a sample believed, or suspected, to be of female origin.
14. A method according to any preceding Claim wherein said methodology employs the use of a standard wherein bone from an individual whose age is known is analysed in parallel with a sample of bone whose "age at death" is to be determined.
15. A method according to Claim 14 wherein a plurality of standards are used.
16. A method according to Claim 15 wherein said standards comprise bone from at least one relatively young individual and bone from at least one relatively old individual.
17. A method according to Claim 16 wherein bone from an individual of 30 years of age + 5 years is used as one standard and bone from an individual of 70 years of age + 5 years is used as a second standard.
18. Means for performing the methodology according to any preceding Claim comprising a resin block containing a sample of bone whose age is to be determined and at least one standard according to Claims 14 to 17.
PCT/GB2004/000125 2003-02-07 2004-01-15 Age determination on death Ceased WO2004070345A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0302825.5 2003-02-07
GB0302825A GB0302825D0 (en) 2003-02-07 2003-02-07 Age determination of death

Publications (2)

Publication Number Publication Date
WO2004070345A2 true WO2004070345A2 (en) 2004-08-19
WO2004070345A3 WO2004070345A3 (en) 2004-11-04

Family

ID=9952614

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2004/000125 Ceased WO2004070345A2 (en) 2003-02-07 2004-01-15 Age determination on death

Country Status (2)

Country Link
GB (1) GB0302825D0 (en)
WO (1) WO2004070345A2 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2674768C1 (en) * 2017-06-30 2018-12-13 федеральное государственное автономное образовательное учреждение высшего образования Первый Московский государственный медицинский университет имени И.М. Сеченова Министерства здравоохранения Российской Федерации (Сеченовский университет) Method for determining the biological age of a corpse
CN116580153A (en) * 2023-05-12 2023-08-11 北京铁路公安局石家庄公安处 Method for judging age point of 60 years of male individuals of Chinese crowd
US12330211B2 (en) 2018-06-20 2025-06-17 Relativity Space, Inc. Multi-diameter wire feeder

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2202280C1 (en) * 2001-08-07 2003-04-20 Российский центр судебно-медицинской экспертизы МЗ РФ Method for determining human being age from morphometric parameters of histological bone tissue preparations

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Section PQ, Week 200337 Derwent Publications Ltd., London, GB; Class P31, AN 2003-390614 XP002293363 & RU 2 202 280 C1 (RUSSIAN MED EXPERTISE CENTRE) 20 April 2003 (2003-04-20) *
HOLDEN J L ET AL: "Scanning electron microscope observations of heat-treated human bone" 1995, FORENSIC SCIENCE INTERNATIONAL, VOL. 74, NR. 1-2, PAGE(S) 29-45 , XP002293360 ISSN: 0379-0738 abstract *
KARASIK D ET AL: "Skeletal age assessment of fossil hominids" July 1998 (1998-07), JOURNAL OF ARCHAEOLOGICAL SCIENCE, VOL. 25, NR. 7, PAGE(S) 689-696 , XP002293358 ISSN: 0305-4403 abstract; table 1 *
LYNNERUP NIELS ET AL: "Intra- and inter-observer variation in histological criteria used in age at death determination based on femoral cortical bone" 16 February 1998 (1998-02-16), FORENSIC SCIENCE INTERNATIONAL, VOL. 91, NR. 3, PAGE(S) 219-230 , XP002293357 ISSN: 0379-0738 abstract; tables 1,2 *
RHO J Y ET AL: "Microstructural elasticity and regional heterogeneity in human femoral bone of various ages examined by nano-indentation" February 2002 (2002-02), JOURNAL OF BIOMECHANICS, VOL. 35, NR. 2, PAGE(S) 189-198 , XP002293356 ISSN: 0021-9290 the whole document *
RITZ S ET AL: "Identification of osteocalcin as a permanent aging constituent of the bone matrix: Basis for an accurate age at death determination" 1996, FORENSIC SCIENCE INTERNATIONAL, VOL. 77, NR. 1-2, PAGE(S) 13-26 , XP002293361 ISSN: 0379-0738 abstract *
THOMAS C D L ET AL: "Determination of age at death using combined morphology and histology of the femur" April 2000 (2000-04), JOURNAL OF ANATOMY, VOL. 196, NR. 3, PAGE(S) 463-471 , XP002293359 ISSN: 0021-8782 abstract *
ZIOUPOS P: "Accumulation of in-vivo fatigue microdamage and its relation to biomechanical properties in ageing human cortical bone" February 2001 (2001-02), JOURNAL OF MICROSCOPY (OXFORD), VOL. 201, NR. 2, PAGE(S) 270-278 , XP002293362 ISSN: 0022-2720 abstract *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2674768C1 (en) * 2017-06-30 2018-12-13 федеральное государственное автономное образовательное учреждение высшего образования Первый Московский государственный медицинский университет имени И.М. Сеченова Министерства здравоохранения Российской Федерации (Сеченовский университет) Method for determining the biological age of a corpse
US12330211B2 (en) 2018-06-20 2025-06-17 Relativity Space, Inc. Multi-diameter wire feeder
CN116580153A (en) * 2023-05-12 2023-08-11 北京铁路公安局石家庄公安处 Method for judging age point of 60 years of male individuals of Chinese crowd
CN116580153B (en) * 2023-05-12 2023-10-27 北京铁路公安局石家庄公安处 A method to determine the 60-year-old age point of male individuals in the Chinese population

Also Published As

Publication number Publication date
WO2004070345A3 (en) 2004-11-04
GB0302825D0 (en) 2003-03-12

Similar Documents

Publication Publication Date Title
Snyder et al. Estimation of mechanical properties of cortical bone by computed tomography
Swiontkowski et al. Torsion and bending analysis of internal fixation techniques for femoral neck fractures: the role of implant design and bone density
Wachtel et al. Dependence of trabecular damage on mechanical strain
Cody et al. Correlations between vertebral regional bone mineral density (rBMD) and whole bone fracture load
Zdeblick et al. Pedicle screw pullout strength: correlation with insertional torque
Kaneko et al. Mechanical properties, density and quantitative CT scan data of trabecular bone with and without metastases
Stout The use of bone histomorphometry in skeletal identification: the case of Francisco Pizarro
Öhman et al. Mechanical testing of cancellous bone from the femoral head: experimental errors due to off-axis measurements
Barger-Lux et al. Bone microstructure in osteoporosis: transilial biopsy and histomorphometry
Tiedeman et al. Quantitative roentgenographic densitometry for assessing fracture healing
Woelfel et al. Human tibial cortical bone with high porosity in type 2 diabetes mellitus is accompanied by distinctive bone material properties
Luo et al. Bone Organic‐Inorganic Phase Ratio Is a Fundamental Determinant of Bone Material Quality
Uppuganti et al. Differences in sensitivity to microstructure between cyclic‐and impact‐based microindentation of human cortical bone
Yoshimura et al. Prevalence of vertebral fractures in a rural Japanese population
Duquette et al. Correlations among bone mineral density, broadband ultrasound attenuation, mechanical indentation testing, and bone orientation in bovine femoral neck samples
Lee et al. A method to develop an in vitro osteoporosis model of porcine vertebrae: histological and biomechanical study
WO2004070345A2 (en) Age determination on death
Royle et al. Applications of X-ray diffraction analysis in crystalline and amorphous body tissues
Serpe et al. Broadband ultrasound attenuation value dependence on bone width in vitro
Kot et al. Assessment of mechanical properties of arterial calcium deposition
Riches et al. Knoop microhardness anisotropy of the ovine radius
Portero et al. Evaluation and development of automatic two-dimensional measurements of histomorphometric parameters reflecting trabecular bone connectivity: correlations with dual-energy x-ray absorptiometry and quantitative ultrasound in human calcaneum
Bandini et al. Indentation size effect of cortical bones submitted to different soft tissue removals
Nicolescu et al. X-RAY diffraction and nanoindentation characterization of bone tissue affected by severe osteoarthritis
Parsch et al. Mechanical stability of structured bone grafts from the anterior iliac crest

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DPEN Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101)
122 Ep: pct application non-entry in european phase